SWM
WST icon

Spire Wealth Management’s West Pharmaceutical WST Stock Holding History

Spire Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Sell
31
-21
-40% -$6.42K ﹤0.01% 1614
2026
Q1 		$13K Sell
52
-36
-41% -$8.96K ﹤0.01% 1546
2025
Q4 		$24.2K Sell
88
-32
-27% -$8.75K ﹤0.01% 1413
2025
Q3 		$31.5K Sell
120
-1
-0.8% -$243 ﹤0.01% 1380
2025
Q2 		$26.5K Sell
121
-47
-28% -$10K ﹤0.01% 1412
2025
Q1 		$37.6K Sell
168
-92
-35% -$25.4K ﹤0.01% 1387
2024
Q4 		$85.2K Sell
260
-4,125
-94% -$1.3M ﹤0.01% 1093
2024
Q3 		$1.32M Sell
4,385
-8,998
-67% -$2.76M 0.04% 313
2024
Q2 		$4.41M Buy
13,383
+13,253
+10,195% +$4.68M 0.16% 137
2024
Q1 		$51.4K Buy
130
+14
+12% +$5.18K ﹤0.01% 1205
2023
Q4 		$39.8K Sell
116
-12
-9% -$4.25K ﹤0.01% 1285
2023
Q3 		$48K Sell
128
-43
-25% -$16.6K ﹤0.01% 1185
2023
Q2 		$65.4K Sell
171
-71
-29% -$25.4K ﹤0.01% 1100
2023
Q1 		$83.8K Sell
242
-29
-11% -$8.47K ﹤0.01% 1019
2022
Q4 		$64K Buy
271
+14
+5% +$3.32K ﹤0.01% 903
2022
Q3 		$63K Buy
257
+2
+0.8% +$609 ﹤0.01% 870
2022
Q2 		$77K Sell
255
-17
-6% -$5.53K ﹤0.01% 1130
2022
Q1 		$112K Sell
272
-21
-7% -$8.22K ﹤0.01% 1125
2021
Q4 		$138K Buy
293
+1
+0.3% +$430 ﹤0.01% 1273
2021
Q3 		$124K Buy
292
+2
+0.7% +$843 ﹤0.01% 1119
2021
Q2 		$104K Sell
290
-16
-5% -$5.29K ﹤0.01% 1170
2021
Q1 		$86K Buy
+306
New +$87.6K ﹤0.01% 1460

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Spire Wealth Management's WST Position: Q2 2026 in Review

Spire Wealth Management reduced its West Pharmaceutical (WST) stake by 40% in Q2 2026, selling an estimated $6.42K and leaving 31 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1614.

Spire Wealth Management first reported a position in WST in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.41M in Q2 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Spire Wealth Management held 31 shares of West Pharmaceutical worth $11.1K as of Q2 2026.
  • Spire Wealth Management sold 21 West Pharmaceutical shares in Q2 2026, an estimated $6.42K.
  • West Pharmaceutical made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1614 holding.
  • Spire Wealth Management first reported a position in West Pharmaceutical in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's West Pharmaceutical position peaked at $4.41M in Q2 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.